Vaxcyte Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $284.0M | $69.0M |
| FY2022 | — | $953.6M | $834.7M |
| FY2023 | — | $1.24B | $397.5M |
| FY2024 | — | $3.31B | $387.9M |
| FY2025 | — | $2.69B | $174.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $284.0M | $69.0M |
| FY2022 | — | $953.6M | $834.7M |
| FY2023 | — | $1.24B | $397.5M |
| FY2024 | — | $3.31B | $387.9M |
| FY2025 | — | $2.69B | $174.0M |